Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Navidea Biopharmaceuticals (NAVB)  
$0.15 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 26,320,000
Market Cap: 3.83(M)
Last Volume: 169,426 Avg Vol: 168,964
52 Week Range: $0.1454 - $0.1454
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Related Products

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Co. is developing multiple precision-targeted products based on its Manocept™ platform to improve patient care by identifying the sites and pathways of undetected disease and enable diagnostic, clinical decision-making and targeted treatment. Co.'s business is focused on two primary types of drug products: diagnostic substances, including Tc99m tilmanocept and other diagnostic applications of its Manocept platform; and therapeutic development programs, including therapeutic applications of its Manocept platform.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-07 2023-12-05 2023-06-06 2022-06-06

   
Records found: 411
  Page 17 of 17  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Aschinger Carl J Jr Director   –       •      –    2004-09-01 4/A B $0.43 $3,500 D/D 8,000 8,000 2.31     -
   Bupp David C CEO and President   •       •      –    2004-08-19 4 B $0.39 $3,900 D/D 10,000 350,500 2.73     -
   Blair Anthony K VP-Manufacturing & Operations   •       –      –    2004-08-17 4 B $0.40 $7,900 D/D 20,000 50,000 2.74     -
   Blair Anthony K VP-Manufacturing & Operations   •       –      –    2004-08-13 4 B $0.40 $12,000 D/D 30,000 30,000 2.74     -
   Bupp David C CEO and President   •       •      –    2004-05-25 4 B $0.43 $4,300 D/D 10,000 340,500 2.73     -
   Katz Nancy E Director   –       •      –    2004-05-24 4 B $0.45 $1,080 D/D 2,400 2,400 2.31     -
   Miller Fred B Director   –       •      –    2004-05-21 4 B $0.47 $4,800 I/I 10,000 11,000 2.1     -
   Bupp David C CEO and President   •       •      –    2004-05-21 4 B $0.47 $6,580 D/D 14,000 330,500 2.81     -
   Bupp David C CEO and President   •       •      –    2004-05-18 4 B $0.50 $7,500 D/D 15,000 316,500 2.81     -
   Bupp David C CEO and President   •       •      –    2004-04-09 4 GD $0.00 $0 D/D 15,000 301,500     -
   Linder Richard N Jr VP Sales & MarketingOfficer   •       –      –    2003-11-01 3 IO $0.00 $0 D/D 0 21,000     -

  411 Records found
  Previous  10  11  12  13  14  15  16  17    
  Page 17 of 17
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed